CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
chemotherapy regimen for the treatment of B-cell acute lymphoblastic leukemia. Part 1 of the study will optimize the dose of study drug (rux...
Phase 2
Austin, Texas, United States and 110 other locations
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SG...
Phase 1
Austin, Texas, United States and 11 other locations
to patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia (B-ALL). The purpose of this study is to evaluate the safety and...
Phase 1, Phase 2
Austin, Texas, United States and 18 other locations
This is a Phase 1-2, multicenter, international, single-arm, open-label study designed to identify a recommended dose of bosutinib administered orall...
Phase 1, Phase 2
Austin, Texas, United States and 58 other locations
chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute myeloid leukemia...
Phase 3
Austin, Texas, United States and 271 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML) with certain genetic al...
Phase 1
Austin, Texas, United States and 43 other locations
designed to evaluate progression-free survival (PFS) endpoint for acalabrutinib versus (vs) ibrutinib in previously treated chronic lymphocytic leukemia...
Phase 3
Round Rock, Texas, United States and 130 other locations
Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess the ...
Phase 3
Austin, Texas, United States and 69 other locations
This will be a multicenter Phase II open-label study of asciminib in CML-CP patients who have been previously treated with one prior ATP- binding sit...
Phase 2
Austin, Texas, United States and 79 other locations
levels of Pirtobrutinib in participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), who have received 1-3 l...
Phase 2
Austin, Texas, United States and 136 other locations
Clinical trials
Research sites
Resources
Legal